(Reuters Health) – The proportion of boys and young men in the U.S. receiving the human papillomavirus (HPV) vaccine has more than tripled since 2011, new research shows. Among 9- to 26-year-old males, 27 percent had received at least one dose of the vaccine i... More »
By Gene Emery(Reuters Health) – New evidence from a Danish nationwide study suggests that Sanofi Pasteur’s quadrivalent human papillomavirus vaccine More »
We use cookies!
By using this site you agree to the use of cookies, more info.